Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity
- PMID: 21905403
Overview of the clinical evidence for the use of NovaMin in providing relief from the pain of dentin hypersensitivity
Abstract
Dentin hypersensitivity is a common condition that affects the adult population worldwide. NovaMin is technically described as amorphous sodium calcium phosphosilicate, and has been shown in laboratory studies to rapidly occlude dentin tubules and form a protective hydroxyapatite-like layer on the dentin surface. A number of clinical studies investigating the efficacy of NovaMin for the relief of pain from dentin hypersensitivity have been conducted in the United States, Ireland, China, and India. This article reviews the available literature and finds support based on randomized controlled clinical trials for the use of NovaMin in anhydrous toothpaste formulations in providing relief of pain from dentin hypersensitivity.
Similar articles
-
Development of a fluoridated, daily-use toothpaste containing NovaMin technology for the treatment of dentin hypersensitivity.J Clin Dent. 2011;22(3):59-61. J Clin Dent. 2011. PMID: 21905398 No abstract available.
-
A clinical study of the effect of calcium sodium phosphosilicate on dentin hypersensitivity--proof of principle.J Clin Dent. 2010;21(3):77-81. J Clin Dent. 2010. PMID: 21207918 Clinical Trial.
-
Novel clinical applications of Colgate Sensitive Pro-Relief in the management of dentin hypersensitivity.J Clin Dent. 2012;23(1):7-10. J Clin Dent. 2012. PMID: 22435318 No abstract available.
-
Recent advances in dentin hypersensitivity: clinically proven treatments for instant and lasting sensitivity relief.Am J Dent. 2010 May;23 Spec No A:3A-13A. Am J Dent. 2010. PMID: 21284246 Review.
-
Advances in the clinical management of dentin hypersensitivity: a review of recent evidence for the efficacy of dentifrices in providing instant and lasting relief.J Clin Dent. 2011;22(4):100-7. J Clin Dent. 2011. PMID: 22403985 Review.
Cited by
-
The Effectiveness of Calcium Phosphates in the Treatment of Dentinal Hypersensitivity: A Systematic Review.Bioengineering (Basel). 2023 Apr 6;10(4):447. doi: 10.3390/bioengineering10040447. Bioengineering (Basel). 2023. PMID: 37106634 Free PMC article. Review.
-
Comparative Analysis of CPP-ACP, Tricalcium Phosphate, and Hydroxyapatite on Assessment of Dentinal Tubule Occlusion on Primary Enamel Using SEM: An In Vitro Study.Int J Clin Pediatr Dent. 2019 Sep-Oct;12(5):371-374. doi: 10.5005/jp-journals-10005-1680. Int J Clin Pediatr Dent. 2019. PMID: 32440039 Free PMC article.
-
Clinical study to monitor dentinal hypersensitivity with episodic use of a desensitising dentifrice.BDJ Open. 2017 Jun 23;3:17011. doi: 10.1038/bdjopen.2017.11. eCollection 2017. BDJ Open. 2017. PMID: 29789771 Free PMC article.
-
Evaluation of Dentifrice Containing Nano-hydroxyapatite for Dentinal Hypersensitivity: A Randomized Controlled Trial.J Int Oral Health. 2015 Aug;7(8):118-22. J Int Oral Health. 2015. PMID: 26464553 Free PMC article.
-
The role of fluoride in the preventive management of dentin hypersensitivity and root caries.Clin Oral Investig. 2013 Mar;17 Suppl 1(Suppl 1):S63-71. doi: 10.1007/s00784-012-0916-9. Epub 2012 Dec 28. Clin Oral Investig. 2013. PMID: 23271217 Free PMC article. Review.